In women over 35 years of age who smoke, does mirena (levonorgestrel-releasing intrauterine system) reduce the risk of DVTs compared to oral contraceptives?
Marshall, M.; Jordan, K.; Brand, J.L.; Welborn, T.L.
Journal of the Oklahoma State Medical Association 106(9): 362-363
2013
ISSN/ISBN: 0030-1876 PMID: 24354055 Document Number: 577796
Document emailed within 1 workday
Related Documents
Hidalgo, M.; Bahamondes, L.; Perrotti, M.; Diaz, J.; Dantas-Monteiro, C.; Petta, C. 2002: Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years Contraception 65(2): 129-132Suhonen, S.; Haukkamaa, M.; Jakobsson, T.; Rauramo, I. 2004: Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study Contraception 69(5): 407-412
Jóźwik, M.; Jóźwik, M.; Modzelewska, B.; Niewińska, M.; Jóźwik, Mł. 2015: Levonorgestrel-releasing intrauterine system Mirena® (Bayer) for the prevention and treatment of endometrial adenocarcinoma and the incidence of other malignancies in women Ginekologia Polska 86(4): 305-310
Godfrey, E.M.; Memmel, L.M.; Neustadt, A.; Shah, M.; Nicosia, A.; Moorthie, M.; Gilliam, M. 2010: Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A Contraception 81(2): 123-127
Herman, M.C.; van den Brink, M.J.; Geomini, P.M.; van Meurs, H.S.; Huirne, J.A.; Eising, H.P.; Timmermans, A.; Pijnenborg, J.M.A.; Klinkert, E.R.; Coppus, S.F.; Nieboer, T.E.; Catshoek, R.; van der Voet, L.F.; van Eijndhoven, H.W.F.; Graziosi, G.C.M.; Veersema, S.; van Kesteren, P.J.; Langenveld, J.; Smeets, N.A.C.; van Vliet, H.A.A.M.; van der Steeg, J.W.; Lisman-van Leeuwen, Y.; Dekker, J.H.; Mol, B.W.; Berger, M.Y.; Bongers, M.Y. 2013: Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial Bmc Women's Health 13: 32
Jick, S.S.; Hernandez, R.K. 2011: Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data Bmj 342: D2151
Ng, Y.W.; Liang, S.; Singh, K. 2009: Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study Contraception 79(1): 24-28
Chen, X.; Wu, X.; Zhu, H. 2014: Acute urticaria as a side effect of the Mirena® (levonorgestrel-releasing intrauterine system): a case report Bmc Research Notes 7: 209
Imperato, F.; Perniola, G.; Mossa, B.; Marziani, R.; Perniola, F.; Stragapede, B.; Napolitano, C. 2002: The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years) Minerva Ginecologica 54(3): 271-278
Shaamash, A.H.; Sayed, G.H.; Hussien, M.M.; Shaaban, M.M. 2005: A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development Contraception 72(5): 346-351
Shaamash, A.H.; Sayed, G.H.; Hussien, M.M.; Shaaban, M.M. 2005: A comparative study of the levonorgestrel-releasing intrauterine system Mirena® versus the Copper T380A intrauterine device during lactation : breast-feeding performance, infant growth and infant development Contraception (Stoneham) 72(5): 346-351
Soini, T.; Hurskainen, R.; Grénman, S.; Mäenpää, J.; Paavonen, J.; Pukkala, E. 2014: Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland Obstetrics and Gynecology 124(2 Part 1): 292-299
Dubuisson, J.B.; Mugnier, E. 2002: Acceptability of the levonorgestrel-releasing intrauterine system after discontinuation of previous contraception: Results of a French clinical study in women aged 35 to 45 years Contraception 66(2): 121-128
Wong, A.Y.K.; Tang, L.C.H.; Chin, R.K.H. 2010: Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial Australian and New Zealand Journal of Obstetrics and Gynaecology 50(3): 273-279
Toivonen, J.; Luukkainen, T.; Allonen, H. 1991: Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices Obstetrics and Gynecology 77(2): 261-264
Toivonen, J.; Luukkainen, T.; Allonen, H. 1991: Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices Obstetrics and Gynecology 77(2): 261-264
Vaughan, D.; Byrne, P. 2012: An evaluation of the simultaneous use of the levonorgestrel-releasing intrauterine device (LNG-IUS, Mirena®) combined with endometrial ablation in the management of menorrhagia Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 32(4): 372-374
Daud, S.; Ewies, A.A.A. 2008: Levonorgestrel-releasing intrauterine system: why do some women dislike it? Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 24(12): 686-690
Lan, S.; Ling, L.; Jianhong, Z.; Xijing, J.; Lihui, W. 2013: Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis Journal of International Medical Research 41(3): 548-558
Charlton, F.; Otton, G.; Hedges, A.; Scurry, J. 2014: Endometrial granulomas with Levonorgestrel Intrauterine System (Mirena) Pathology 46(5): 457-458